Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) had its target price hoisted by Robert W. Baird from $28.00 to $32.00 in a research report released on Monday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. CPRX has been the topic of a number of other reports. HC Wainwright reiterated a “buy” […]
Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) had its target price hoisted by Robert W. Baird from $28.00 to $32.00 in a research report released on Monday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. CPRX has been the topic of a number of other reports. HC Wainwright reiterated a “buy” […]
